C81.35
Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Lymphocyte depleted Hodgkin lymphoma is a rare and aggressive subtype of Hodgkin lymphoma, primarily affecting lymph nodes in specific areas such as the inguinal region and the lower limbs. This form of lymphoma is characterized by a reduced number of lymphocytes and distinctive pathological features. Recognizing the symptoms and understanding the nature of this disease can aid in timely diagnosis and management.
Causes & Symptoms
Clinical Causes: The exact cause of lymphocyte depleted Hodgkin lymphoma remains unknown. Its development is believed to involve genetic mutations that lead to abnormal lymphocyte growth. Environmental factors, such as exposure to certain chemicals or radiation, may play a role, although this is not definitively established. Immunodeficiency states or infections might predispose individuals to this form of lymphoma.
Key Symptoms: Swelling or lumps in the affected lymph nodes, particularly in the groin and lower limbs Persistent fatigue or weakness Unexplained weight loss Fever and night sweats Itching, especially over affected areas Pain or discomfort in the affected regions Localized swelling, redness, or warmth
Diagnostic & Treatment
Diagnosis Path: Initial assessment includes physical examination focusing on swollen lymph nodes. Imaging studies such as CT or PET scans help identify the extent of disease spread. A biopsy of the affected lymph node is crucial for definitive diagnosis, where histological examination reveals characteristic features of lymphocyte depletion. Laboratory tests, including blood counts and markers, support the diagnosis. Immunohistochemistry techniques assist in differentiating this subtype from other lymphomas.
Treatment Protocols: Chemotherapy forms the backbone of treatment, often using combination regimens tailored to the disease stage. Radiation therapy may be employed to target specific affected areas, such as inguinal lymph nodes or lower limbs. Stem cell transplantation is considered in cases where the disease is resistant to initial therapies. Supportive care, including management of symptoms and side effects, is vital throughout treatment. Regular follow-up is essential to monitor for recurrence or complications.
Clinical Advice & FAQs
Billing Guidance
Is C81.35 a billable ICD-10 code?
Yes, C81.35 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.35?
Clinical documentation must specify the nature of Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference